ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,868Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 1802

$464K Total Retail Price of All Prescriptions

Rank: 116 out of 1802

460 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LISINOPRIL 371 329 1 3
FUROSEMIDE 362 341 2 5
SIMVASTATIN 334 300 3 1
LEVOTHYROXINE SODIUM 334 311 3 2
OMEPRAZOLE 333 287 5 4
AMLODIPINE BESYLATE 288 280 6 6
METOPROLOL TARTRATE 271 232 7 9
WARFARIN SODIUM 241 191 8 7
HYDROCHLOROTHIAZIDE 224 218 9 8
CITALOPRAM HBR 193 177 10 17
POTASSIUM CHLORIDE 183 164 11 15
SERTRALINE HCL 162 151 12 20
GABAPENTIN 156 111 13 16
METFORMIN HCL 151 131 14 11
ATENOLOL 148 144 15 12
LOSARTAN POTASSIUM 129 126 16 18
METOPROLOL SUCCINATE 115 113 17 13
ATORVASTATIN CALCIUM 112 98 18 14
TRAZODONE HCL 107 88 19 39
SPIRIVA 96 91 20 72
HYDROCODONE-ACETAMINOPHEN 93 45 S3 21 10
OXYCODONE-ACETAMINOPHEN 90 54 S2 22 67
PREDNISONE 82 81 23 33
CLOPIDOGREL 80 69 24 48
QUETIAPINE FUMARATE 75 73 25 54
TRAMADOL HCL 74 64 26 22
TAMSULOSIN HCL 73 70 27 28
RANITIDINE HCL 72 70 28 30
ZOLPIDEM TARTRATE 70 42 29 27
PROAIR HFA 69 45 30 58
ALLOPURINOL 68 64 31 24
ADVAIR DISKUS 64 55 32 32
MORPHINE SULFATE ER 64 24 S2 32 71
LOVASTATIN 62 51 34 25
DIGOXIN 62 52 34 45
PLAVIX 60 55 36 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 55 37 23
DONEPEZIL HCL 59 59 37 26
LANTUS SOLOSTAR 58 58 39 63
ISOSORBIDE MONONITRATE ER 56 56 40 66
LANTUS 54 44 41 47
GLIMEPIRIDE 52 48 42 42
CARVEDILOL 50 36 43 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.